Filtered By:
Infectious Disease: Coronavirus
This page shows you your search results in order of date.
Order by Relevance | Date
Total 2387 results found since Jan 2013.
With the Decongestant SNAFU, the FDA Tries Something New
It’s easy to understand how a medicine like phenylephrine got onto pharmacy shelves in the first place. The common decongestant, used most often as an ingredient in multidrug cold medications like DayQuil and Sudafed PE, was initially designated as “safe and effective” by the Food and Drug Administration (FDA) in 1976, when the agency was newly—and less stringently than today—greenlighting drugs that had been on the market for years before the agency had established any efficacy standards. After a full review of 14 studies (12 unpublished and two published) from pharmaceutical companies—...
Source: TIME: Health - September 14, 2023 Category: Consumer Health News Authors: Haley Weiss Tags: Uncategorized healthscienceclimate Source Type: news
Trump Explains Why He Didn ' t Fire Fauci
Trump Explains Why He Didn't Fire Fauci Authored by Jack Phillips via The Epoch Times (emphasis ours), Dr. Anthony Fauci (R), then-director of the National Institute of Allergy and Infectious Diseases, and then-President Donald Trump participate in the daily coronavirus task force briefing at the…#jackphillips #epochtimes #anthonyfauci #donaldtrump #hughhewitt #trump #florida #rondesantis #rubinreport #fauci
Source: Reuters: Health - September 9, 2023 Category: Consumer Health News Source Type: news
Pro ‐inflammatory markers associated with COVID‐19‐related persistent olfactory dysfunction
ConclusionIFN pathway cytokines were found elevated in the olfactory microenvironment of COVID-19 persistent OD compared to those with no OD and no prior history of COVID-19 infection.
Source: International Forum of Allergy and Rhinology - September 7, 2023 Category: Allergy & Immunology Authors: Sophie S. Jang,
Kwang S. Pak,
Allyssa Strom,
Leslie Gomez,
Laura Kim,
Taylor A. Doherty,
Adam S. DeConde,
Allen F. Ryan,
Carol H. Yan Tags: ORIGINAL ARTICLE Source Type: research
Comprehensive care of adults with respiratory diseases must include vaccines
Vaccines are among the most effective tools we have to improve and save lives, but only if they are administered to eligible patients. In this issue, Naeger et al1 highlight the major opportunities that the health care community has to achieve high adult vaccination rates. These vaccines include those for prevention of coronavirus disease 2019 (COVID-19), pneumococcal, and influenza, diseases that respiratory health professionals are most aware of, plus pertussis (in Tdap), herpes zoster (HZ, shingles), and as of May 3, 2023, respiratory syncytial viral, for which adults with asthma and chronic obstructive pulmonary diseas...
Source: Annals of Allergy, Asthma and Immunology - September 1, 2023 Category: Allergy & Immunology Authors: Barbara P. Yawn, Dennis Williams, Gregory Poland Tags: Editorial Source Type: research
A qualitative investigation into vaccine hesitancy and confidence among people managing allergy
Vaccine hesitancy is multifactorial, and among atopic individuals, is exacerbated by documented, but rare, cases of allergic reactions to coronavirus disease 2019 (COVID-19) vaccines.1 –3 Furthermore, conflicting information regarding the safety of COVID-19 vaccines may have caused confusion among individuals with a history of severe allergies. We performed semistructured qualitative interviews to better understand how some adults and families managing allergy perceive vaccine m essaging and what influences their decisions to be vaccinated.
Source: Annals of Allergy, Asthma and Immunology - August 28, 2023 Category: Allergy & Immunology Authors: Ayel Luis R. Batac, Kaitlyn A. Merrill, Michael A. Golding, Elissa M. Abrams, Philippe B égin, Moshe Ben-Shoshan, Erika Ladouceur, Leslie E. Roos, Vladan Protudjer, Jennifer L.P. Protudjer Tags: Letters Source Type: research
Anxiety in adults with asthma during the coronavirus disease 2019 pandemic: a Canadian perspective
Asthma is a chronic airway inflammatory disease that affects millions of Canadians and often contributes to higher levels of anxiety among patients. Since the coronavirus disease 2019 (COVID-19) pandemic was a...
Source: Allergy, Asthma and Clinical Immunology - August 23, 2023 Category: Allergy & Immunology Authors: Sophia Linton, Kayley Xu, Lubnaa Hossenbaccus, Hannah Botting, Sarah Garvey, Adam Sunavsky, Lisa M. Steacy, Dean A. Tripp and Anne K. Ellis Tags: Research Source Type: research
Population-level trends in asthma and chronic obstructive pulmonary disease emergency department visits and hospitalizations before and during the coronavirus disease 2019 pandemic in the United States
Previous studies have identified reductions in exacerbations of chronic lung disease in many locales after onset of the coronavirus disease 2019 (COVID-19) pandemic.
Source: Annals of Allergy, Asthma and Immunology - August 22, 2023 Category: Allergy & Immunology Authors: Adam Gaffney, David U. Himmelstein, Steffie Woolhandler Source Type: research
News at a glance: A win for obesity drugs, NIH unionization roadblocks, and Mexican fireflies under threat
CONSERVATION
Researchers raise alarm over threat to Mexican fireflies
Scientists from the International Union for Conservation of Nature (IUCN) last week delivered a letter to the Mexican government requesting it regulate tourism centered on the threatened firefly species
Photinus palaciosi
. Endemic to Mexico’s Tlaxcala forests,
P. palaciosi
is one of the few species that glow in synchrony, offering an annual spectacle that attracts thousands of visitors during summer mating season. The letter describes how littering, artificial light, and noise interfere with the insects’ courtship and eg...
Source: ScienceNOW - August 10, 2023 Category: Science Source Type: news
News at a glance: A win for obesity drugs, a new infectious disease institute head, and Mexican fireflies under threat
CONSERVATION
Researchers raise alarm over threat to Mexican fireflies
Scientists from the International Union for Conservation of Nature (IUCN) last week delivered a letter to the Mexican government requesting it regulate tourism centered on the threatened firefly species
Photinus palaciosi
. Endemic to Mexico’s Tlaxcala forests,
P. palaciosi
is one of the few species that glow in synchrony, offering an annual spectacle that attracts thousands of visitors during summer mating season. The letter describes how littering, artificial light, and noise interfere with the insects’ courtship and eg...
Source: Science of Aging Knowledge Environment - August 10, 2023 Category: Geriatrics Source Type: research
Asthma in elderly and coronavirus disease 2019
Once the first wave of severe acute respiratory syndrome coronavirus 2 novel coronavirus disease subsided, the attempt was made to investigate both short- and long-term potential consequences, especially in high-risk patient cohorts including those after prolonged hospitalization and intensive therapy.1 Symptoms persisting 3 to 6 months after acute coronavirus disease 2019 (COVID-19) (post –COVID-19 syndrome) have been described.2-5 Currently, there is a lack of information on post–COVID-19 consequences in elderly patients with asthma.
Source: Annals of Allergy, Asthma and Immunology - August 7, 2023 Category: Allergy & Immunology Authors: Sergey N. Avdeev, Viliya V. Gaynitdinova, Anna A. Pozdnakova, Svetlana Yu Chikina, Karina A. Kosobokova Tags: Letters Source Type: research
Asthma in elderly and COVID-19: results of 90-day post-hospital follow-up
Once the first wave of SARS-CoV-2 novel coronavirus disease subsided, the attempt was made to investigate both short- and long-term potential consequences, especially in high-risk patient cohorts including those after prolonged hospitalization and intensive therapy1. Symptoms persisting 3 - 6 months after acute COVID-19 (post-COVID syndrome) have been described 2,3,4,5. Currently, there is a lack of information on post-COVID consequences in elderly patients with asthma. Asthma in elderly is known to have specific features, such as high comorbidity, use of multiple pharmacological agents, individual response to treatment, d...
Source: Annals of Allergy, Asthma and Immunology - August 7, 2023 Category: Allergy & Immunology Authors: Sergey N. Avdeev, Viliya V. Gaynitdinova, Anna A. Pozdnakova, Svetlana Yu Chikina, Karina A. Kosobokova Tags: Letters Source Type: research
Did the coronavirus disease 2019 pandemic change asthma prevalence?
Ann Allergy Asthma Immunol. 2023 Aug;131(2):141-142. doi: 10.1016/j.anai.2023.05.022.NO ABSTRACTPMID:37536872 | DOI:10.1016/j.anai.2023.05.022
Source: Annals of Allergy, Asthma and Immunology - August 3, 2023 Category: Allergy & Immunology Authors: Rebecca Koenigsberg Mitchell H Grayson Source Type: research
